AKT3 and silicosis: Consistent with the results of the silicosis mouse model, in TC-1 cells treated with TGF-β1, we discovered that the mRNA expression of Akt3 increased in a dose-dependent manner, with the highest expression at 10 ng/mL TGF-β1 (Figure 4C).